Argentina’s Congress approved a law that will create a regulatory framework for public and private investments in the production of pharma-grade cannabis products.
The law still needs to be signed by President Alberto Fernandez.
Lance Lambert, VP of marketing and business development for Nevada-based brand GreenBroz Inc., said the country's population of over 45 million is "one to watch and be ready to take advantage of when the time is right."
The law passed the Senate last year, with ample support from state governors who are betting on cannabis to promote economic growth and sustainable development.
The legislation does not legalize recreational cannabis, rather, creates the ARICCAME (Regulatory Agency for Hemp and Medicinal Cannabis), the agency that will regulate the production of cannabis for medicinal and industrial purposes.
The agency will coordinate with state governments when and if cannabis and hemp licenses are approved, gaining a prominent role in the regulatory process.
The law also provides cannabis businesses with access to traditional banking and establishes a streamlined regulatory process for hemp producers.
Thursday's decision in the Chamber of Deputies has been pending since July of last year when, after being proposed by the national government, it was later blocked by the opposition over disagreement on the details.
Divided Opinions
Representatives in favor of the bill emphasized the importance of legislation to guarantee safe access to healthcare, boost economic benefits and exports, and diversify economies beyond the central “Pampa” region.
Meanwhile, opponents of the bill said the legislation enlarges the government and challenges the imposition of a national tax on cannabis. There were also cultural arguments against cannabis. Conservative members of the lower chamber referred to the cannabis industry as "the advance of drug trafficking" and legitimization of the consumption of illegal substances.
“This law provides for different types of authorizations and licenses. Priority will be given to projects that promote regional development and that incorporate SMEs“, said Rep. Mara Brawer, co-sponsor of the bill.
There were a few surprises as the debate played out.
Rep. Martin Tetaz, a supporter of market deregulation and fiscal austerity, often criticized by the left, said he was in favor of the law and called for the legalization of recreational cannabis.
“I am in favor of complete legalization, and against a 'paternalistic state'. Society does not tolerate more bureaucracy,” Tetaz said in reference to the regulatory agency that will serve as the supervising body of the cannabis production chain.
Argentina's cannabis marketplace shows signs of promise as incremental progress has been underway for several years. The Supreme Court decriminalized the use of small amounts of cannabis in 2009. In 2017, the country approved the import of cannabis products with a doctor's prescription, and in 2020, a bill authorized home cultivation for medical patients.
Image Via El Planteo.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.